Comparative Pharmacology
Head-to-head clinical analysis: DELFLEX LM W DEXTROSE 3 5 IN PLASTIC CONTAINER versus DIANEAL PD 2 W DEXTROSE 4 25 IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: DELFLEX LM W DEXTROSE 3 5 IN PLASTIC CONTAINER versus DIANEAL PD 2 W DEXTROSE 4 25 IN PLASTIC CONTAINER.
DELFLEX-LM W/ DEXTROSE 3.5% IN PLASTIC CONTAINER vs DIANEAL PD-2 W/ DEXTROSE 4.25% IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
DELFLEX-LM W/ DEXTROSE 3.5% is a peritoneal dialysis solution. Its mechanism of action involves osmotic ultrafiltration across the peritoneal membrane, facilitated by high dextrose concentration, to remove excess fluid and waste products (e.g., urea, creatinine) from the blood in patients with end-stage renal disease.
DIANEAL PD-2 with 4.25% dextrose is a peritoneal dialysis solution that creates an osmotic gradient across the peritoneal membrane, promoting diffusion and convection of solutes and ultrafiltration of fluid from the blood into the peritoneal cavity. Dextrose is absorbed systemically and metabolized, providing caloric load.
Intraperitoneal: 1.5% to 4.25% dextrose solution; 2 to 2.5 L per exchange, typically 4 exchanges per 24 hours; dwell time 4 to 6 hours.
Intraperitoneal administration: 2 to 2.5 L per exchange, 4 exchanges per day (continuous ambulatory peritoneal dialysis) or as prescribed for automated peritoneal dialysis. Dextrose 4.25% used for ultrafiltration. Dose adjusted based on patient's peritoneal membrane transport characteristics and fluid status.
None Documented
None Documented
Not applicable for dextrose; for lactate/bicarbonate buffer components, half-life is approximately 2-4 hours in peritoneal cavity with systemic absorption minimal. Clinical context: continuous dialysis maintains steady-state.
Not applicable as glucose is continuously absorbed; systemic half-life of absorbed dextrose ~1-2 hours
Peritoneal dialysis: Removal of waste products (urea, creatinine) via peritoneal membrane; approximately 60-80% of urea is removed during a 4-6 hour dwell. Biliary/fecal: minimal (<5%). Renal: negligible as drug is primarily used in renal failure.
Renal, peritoneal; ~80% removed via peritoneal dialysis, remainder metabolized to CO2 and water
Category C
Category C
Peritoneal Dialysis Solution
Peritoneal Dialysis Solution